These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20816985)

  • 1. Investigation of an anomalously accelerating substitution in the folding of a prototypical two-state protein.
    Lawrence C; Kuge J; Ahmad K; Plaxco KW
    J Mol Biol; 2010 Oct; 403(3):446-58. PubMed ID: 20816985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding.
    Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):260-88. PubMed ID: 7490748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain in the folding nucleus of chymotrypsin inhibitor 2.
    Ladurner AG; Itzhaki LS; Fersht AR
    Fold Des; 1997; 2(6):363-8. PubMed ID: 9427010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding of circular and permuted chymotrypsin inhibitor 2: retention of the folding nucleus.
    Otzen DE; Fersht AR
    Biochemistry; 1998 Jun; 37(22):8139-46. PubMed ID: 9609709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of experimental and calculated folding free energies for hydrophobic deletion mutants of chymotrypsin inhibitor 2: free energy perturbation calculations using transition and denatured states from molecular dynamics simulations of unfolding.
    Pan Y; Daggett V
    Biochemistry; 2001 Mar; 40(9):2723-31. PubMed ID: 11258883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for nucleation sites in smaller fragments of chymotrypsin inhibitor 2.
    Itzhaki LS; Neira JL; Ruiz-Sanz J; de Prat Gay G; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):289-304. PubMed ID: 7490749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of isomerisation of peptidyl-proline bonds as a probe for interactions in the physiological denatured state of chymotrypsin inhibitor 2.
    Tan YJ; Oliveberg M; Otzen DE; Fersht AR
    J Mol Biol; 1997 Jun; 269(4):611-22. PubMed ID: 9217264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of rates of protein folding: the nucleation-condensation mechanism and its implications.
    Fersht AR
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10869-73. PubMed ID: 7479900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementation of peptide fragments of the single domain protein chymotrypsin inhibitor 2.
    Ladurner AG; Itzhaki LS; de Prat Gay G; Fersht AR
    J Mol Biol; 1997 Oct; 273(1):317-29. PubMed ID: 9367764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobic core mutations in CI2 globally perturb fast side-chain dynamics similarly without regard to position.
    Whitley MJ; Zhang J; Lee AL
    Biochemistry; 2008 Aug; 47(33):8566-76. PubMed ID: 18656953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the hydrophobic core in the transition state for folding of chymotrypsin inhibitor 2: a critical test of the protein engineering method of analysis.
    Jackson SE; elMasry N; Fersht AR
    Biochemistry; 1993 Oct; 32(42):11270-8. PubMed ID: 8218192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing nature of the protein folding transition state: implications for the shape of the free-energy profile for folding.
    Oliveberg M; Tan YJ; Silow M; Fersht AR
    J Mol Biol; 1998 Apr; 277(4):933-43. PubMed ID: 9545382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism.
    Neira JL; Davis B; Ladurner AG; Buckle AM; Gay Gde P; Fersht AR
    Fold Des; 1996; 1(3):189-208. PubMed ID: 9079381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved residues and the mechanism of protein folding.
    Shakhnovich E; Abkevich V; Ptitsyn O
    Nature; 1996 Jan; 379(6560):96-8. PubMed ID: 8538750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine, alanine or glycine repeats inserted into the loop of a protein have minimal effects on stability and folding rates.
    Ladurner AG; Fersht AR
    J Mol Biol; 1997 Oct; 273(1):330-7. PubMed ID: 9367765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of the transition state for the association of two fragments of the barley chymotrypsin inhibitor 2 to generate native-like protein: implications for mechanisms of protein folding.
    de Prat Gay G; Ruiz-Sanz J; Davis B; Fersht AR
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10943-6. PubMed ID: 7971988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design of Chymotrypsin Inhibitor 2 by Optimizing Non-Native Interactions.
    B da Silva F; M de Oliveira V; Sanches MN; Contessoto VG; Leite VBP
    J Chem Inf Model; 2020 Feb; 60(2):982-988. PubMed ID: 31794216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement of the position of the transition state in protein folding.
    Matouschek A; Otzen DE; Itzhaki LS; Jackson SE; Fersht AR
    Biochemistry; 1995 Oct; 34(41):13656-62. PubMed ID: 7577956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.